; (2) require intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy; and (3) meet any other eligibility requirements specified by the Secretary. (e) Payment (1) Intravenous immune globulin For intravenous immune globulin furnished under this section, the Secretary shall make payment using the payment methodology under section 1847A of the Social Security Act ( 42 U.S.C. 1395w–3a ). (2) Other items and services (A) In general The Secretary shall establish, subject to subparagraph (B), a per-visit payment amount for items and services (other than intravenous immune globulin) needed for the in-home infusion of intravenous immune globulin for the treatment of chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy based on the national per visit low-utilization payment amount under the prospective payment system for home health services established under section 1895 of the Social Security Act ( 42 U.S.C. 1395fff ). (B) Limitation In establishing the per-visit payment amount established under subparagraph (A) for items and services described in such subparagraph, the Secretary shall consider— (i) including a component for requisite nursing care; (ii) establishing an appropriate furnishing fee for intravenous immune globulin similar to the separate payment for clotting factors under section 1842(o)(5) of the Social Security Act ( 42 U.S.C. 1395u(o)(5) ); (iii) otherwise acknowledging the length of infusions for individuals needing in-home infusion of intravenous globulin for treatment described in subparagraph (A)